1 |
Wei Z, Xie Y, Wei M, Zhao H, Ren K, Feng Q, Xu Y. New insights in ferroptosis: Potential therapeutic targets for the treatment of ischemic stroke. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1020918] [Reference Citation Analysis]
|
2 |
Yasin M, Shahid W, Ashraf M, Saleem M, Muzaffar S, Aziz-Ur-Rehman, Ejaz SA, Mahmood HMK, Bhattarai K, Riaz N. Targeting new N-furfurylated 4-chlorophenyl-1,2,4-triazolepropionamide hybrids as potential 15-lipoxygenase inhibitors supported with in vitro and in silico studies. J Biomol Struct Dyn 2022;:1-17. [PMID: 35699270 DOI: 10.1080/07391102.2022.2080765] [Reference Citation Analysis]
|
3 |
Kain V, Mat Y, Halade GV. Interaction of aging with lipoxygenase deficiency initiates hypersplenism, cardiac dysfunction, and profound leukocyte directed non-resolving inflammation. Geroscience 2021. [PMID: 34932185 DOI: 10.1007/s11357-021-00496-x] [Reference Citation Analysis]
|
4 |
B Gowda S, Gowda D, Kain V, Chiba H, Hui SP, Chalfant CE, Parcha V, Arora P, Halade GV. Sphingosine-1-phosphate interactions in the spleen and heart reflect extent of cardiac repair in mice and failing human hearts. Am J Physiol Heart Circ Physiol 2021;321:H599-611. [PMID: 34415189 DOI: 10.1152/ajpheart.00314.2021] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
|